Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ChemDiv, a leading chemistry-driven global contract research organization, has entered into discovery collaboration with Achaogen, South San Francisco, California.
Subscribe to our email newsletter
Applying its expertise in medicinal and synthetic chemistry, ChemDiv will support Achaogen in identifying and developing novel antibacterial compounds.
Heinz Moser, senior vice president for chemistry at Achaogen, said: “We are pleased to be working with ChemDiv on this important medicinal chemistry effort to optimize SOS pathway inhibitors discovered by Achaogen. These inhibitors could prove to be powerful new tools in the battle against antimicrobial resistance.”